Kintara Therapeutics (KTRA) Competitors

$0.24

+0.03 (+13.97%)

(As of 07/26/2024 ET)

KTRA vs. MLND, RLYB, IMMX, BRNS, LPTX, OCUP, AVTE, RPHM, DRRX, and LTRN

Should you be buying Kintara Therapeutics stock or one of its competitors? The main competitors of Kintara Therapeutics include Millendo Therapeutics (MLND), Rallybio (RLYB), Immix Biopharma (IMMX), Barinthus Biotherapeutics (BRNS), Leap Therapeutics (LPTX), Ocuphire Pharma (OCUP), Aerovate Therapeutics (AVTE), Reneo Pharmaceuticals (RPHM), DURECT (DRRX), and Lantern Pharma (LTRN). These companies are all part of the "medical" sector.

Kintara Therapeutics vs.

Kintara Therapeutics (NASDAQ:KTRA) and Millendo Therapeutics (NASDAQ:MLND) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk.

: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Kintara Therapeutics N/A N/A -$14.65M -$4.07 -0.06
Millendo Therapeutics N/A N/A -$36.41M N/A N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kintara Therapeutics
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Millendo Therapeutics
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: Kintara Therapeutics received 16 more outperform votes than Millendo Therapeutics when rated by MarketBeat users.
Company Underperform Outperform
Kintara Therapeutics Outperform Votes
16
88.89%
Underperform Votes
2
11.11%
Millendo Therapeutics N/A N/A
: Kintara Therapeutics has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500. Comparatively, Millendo Therapeutics has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500.
: In the previous week, Kintara Therapeutics had 2 more articles in the media than Millendo Therapeutics. MarketBeat recorded 2 mentions for Kintara Therapeutics and 0 mentions for Millendo Therapeutics. Kintara Therapeutics' average media sentiment score of 1.44 beat Millendo Therapeutics' score of 0.00 indicating that Kintara Therapeutics is being referred to more favorably in the media.
Company Overall Sentiment
Kintara Therapeutics Positive
Millendo Therapeutics Neutral
: Kintara Therapeutics' return on equity of 0.00% beat Millendo Therapeutics' return on equity.
Company Net Margins Return on Equity Return on Assets
Kintara Therapeutics N/A N/A -257.25%
Millendo Therapeutics N/A -91.03% -72.44%
: 0.6% of Kintara Therapeutics shares are owned by institutional investors. 0.2% of Kintara Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kintara Therapeutics	N/A	N/A	-$14.65M	-$4.07	-0.06
Millendo Therapeutics	N/A	N/A	-$36.41M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kintara Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Millendo Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Underperform	Outperform
Kintara Therapeutics	Outperform Votes 16 88.89%	Underperform Votes 2 11.11%
Millendo Therapeutics	N/A	N/A

Company	Overall Sentiment
Kintara Therapeutics	Positive
Millendo Therapeutics	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Kintara Therapeutics	N/A	N/A	-257.25%
Millendo Therapeutics	N/A	-91.03%	-72.44%

Summary

Kintara Therapeutics beats Millendo Therapeutics on 8 of the 9 factors compared between the two stocks.

Ad Weiss Ratings

The next companies to potentially benefit thanks to Nvidia are …

Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.

Click here to learn more.

Get Kintara Therapeutics News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KTRA vs. The Competition

Export to Excel

Metric	Kintara Therapeutics	Pharmaceutical Industry	Medical Sector	NASDAQ Exchange
Market Cap	$13.54M	$7.05B	$5.31B	$8.19B
Dividend Yield	N/A	2.82%	2.72%	3.96%
P/E Ratio	-0.06	20.22	152.08	18.37
Price / Sales	N/A	291.03	2,071.74	88.82
Price / Cash	N/A	32.58	35.89	34.13
Price / Book	-0.04	5.89	4.95	4.51
Net Income	-$14.65M	$147.89M	$112.29M	$216.36M
7 Day Performance	-2.90%	2.90%	2.73%	1.82%
1 Month Performance	-12.63%	9.07%	6.97%	7.09%
1 Year Performance	-94.55%	4.24%	11.22%	4.88%

Kintara Therapeutics Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MLND Millendo Therapeutics	0 of 5 stars 0.00 / 5 stars	$1.93 -1.0%	N/A	+83.0%	$36.75M	N/A	0.00	12
RLYB Rallybio	3.5902 of 5 stars 3.59 / 5 stars	$1.34 +3.1%	$12.20 +810.4%	-77.0%	$55.54M	N/A	-0.71	30	Short Interest ↓ Positive News Gap Up
IMMX Immix Biopharma	2.6645 of 5 stars 2.66 / 5 stars	$2.08 +1.5%	$10.50 +404.8%	+9.8%	$54.93M	N/A	-2.24	9	Analyst Forecast News Coverage
BRNS Barinthus Biotherapeutics	1.9036 of 5 stars 1.90 / 5 stars	$1.40 -2.7%	$5.50 +292.9%	N/A	$54.64M	$800,000.00	-0.76	130	Short Interest ↑ News Coverage
LPTX Leap Therapeutics	2.6876 of 5 stars 2.69 / 5 stars	$2.07 -1.9%	$10.40 +402.4%	-14.7%	$52.99M	$1.50M	-0.87	54	Positive News
OCUP Ocuphire Pharma	3.6816 of 5 stars 3.68 / 5 stars	$1.99 +2.6%	$18.75 +842.2%	-48.1%	$51.58M	$19.05M	-4.06	14	Short Interest ↓ Gap Up
AVTE Aerovate Therapeutics	3.4018 of 5 stars 3.40 / 5 stars	$1.78 -2.2%	$2.25 +26.4%	-88.0%	$51.30M	N/A	-0.59	20	Short Interest ↓ Positive News Gap Up
RPHM Reneo Pharmaceuticals	3.2146 of 5 stars 3.21 / 5 stars	$1.48 +0.7%	$11.01 +644.1%	-74.9%	$49.46M	N/A	-0.68	8	Positive News
DRRX DURECT	3.2525 of 5 stars 3.25 / 5 stars	$1.59 +9.7%	$27.50 +1,629.6%	-46.6%	$49.35M	$8.55M	-1.67	80	Gap Down
LTRN Lantern Pharma	1.1898 of 5 stars 1.19 / 5 stars	$4.41 -1.6%	N/A	+0.4%	$47.45M	N/A	-2.71	21	Short Interest ↓